The largest database of trusted experimental protocols

4 protocols using dbco peg4 nhs

1

Conjugation of Detector Antibody to Primer-Template Hybrid

Check if the same lab product or an alternative is used in the 5 most similar protocols
The primer–template
hybrid for conjugation to detector antibody was prepared by first
annealing a 5′ azide-modified primer (36.1 μM) and a
linear methylated AluI D6 template (37.9 μM) in NEBNext Quick
Ligation Buffer (New England Biolabs). The mixture was heated at 95
°C for 2 min and allowed to slowly cool to room temperature over
1.5 h. The template was then ligated by adding T4 DNA ligase and incubating
at room temperature for 3 h. After ligation, a 7K MWCO Zeba spin desalting
column (Thermo Fisher Scientific) was used to buffer exchange the
primer–template pair into phosphate buffered saline (PBS) with
1 mM EDTA. The detector antibody (AF6274, R&D Systems) was reconstituted
to 1 mg/mL in PBS and incubated with a 20-fold molar excess of dibenzocyclooctyne-PEG4-N-hydroxysuccinimidyl ester (DBCO-PEG4-NHS, MilliporeSigma)
at room temperature for 30 min before purification with a 10K Amicon
Ultra-0.5 mL centrifugal filter in PBS with 1 mM EDTA. The DBCO-modified
detector antibody was then mixed with a 2-fold molar excess of the
ligated primer-template and incubated at 4 °C overnight. The
antibody–DNA conjugate was aliquoted and stored at −80
°C in PBS with 5 mM EDTA, 0.1% BSA, and 0.02% sodium azide.
+ Open protocol
+ Expand
2

Azide-Modified Primer-Template Conjugation

Check if the same lab product or an alternative is used in the 5 most similar protocols
A 5′ azide-modified primer was annealed to the DNA template for RCA by heating a solution of 33.8 μM primer and 40.6 μM template in NEBNext Quick Ligation Buffer (New England Biolabs) at 95 °C for two minutes and allowing to cool to room temperature over 90 min. Ligation was then performed with addition of T4 DNA ligase and incubation at room temperature for three hours. The ligation reaction was then heated at 65 °C for 10 min to inactivate the ligase, with subsequent cooling to room temperature. The ligation reaction was buffer exchanged into phosphate buffered saline (PBS) with 1 mM EDTA using a 7K MWCO Zeba spin desalting column (Thermo Fisher Scientific). For conjugation, streptavidin (Biolegend 280302) was buffer exchanged into PBS using a 10K Amicon Ultra-0.5 mL centrifugal filter, incubated with a 20-fold molar excess of dibenzocyclooctyne-PEG4-N-hydroxysuccinimidyl ester (DBCO-PEG4-NHS, MilliporeSigma) for 30 min at room temperature, and purified with a 10K Amicon Ultra-0.5 mL centrifugal filter in PBS with 1 mM EDTA. A 2-fold molar excess of the ligated primer-template was then added to the DBCO-modified streptavidin and incubated overnight at 4 °C. The conjugate was stored in aliquots at −80 °C in PBS with 5 mM EDTA, 0.1% BSA, and 0.02% sodium azide.
+ Open protocol
+ Expand
3

Synthesis and Functionalization of FNA

Check if the same lab product or an alternative is used in the 5 most similar protocols
Phosphoramidite reagents used for the synthesis of FNA were purchased from Glen Research (VA, United States): spacer 18 phosphoramidite (10–1918), DBCO-dT-CE phosphoramidite (10–1539), Thiol-Modifier C6 S-S (10–1936), biotin CPG (20–2993). N-terminus azide modified Aβ42 [K(N3)-Aβ42] peptide was purchased from GenScript Biotech (NJ, United States). N-(g-Maleimidobutyryloxysuccinimide ester) GMBS was purchased from Pierce Biotechnology (Grand Island, NY). Streptavidin was obtained from Sigma-Aldrich (MO, United States) and Tris-(2-Carboxyethyl) phosphine-HCl (TCEP-HCl) was purchased from Hampton Research Inc. (CA, United States). 1-(3-aminopropyl) silatrane (APS) was synthesized as previously described (Shlyakhtenko et al., 2013 (link)). β-mercaptoethanol, NHS-PEG4-DBCO and all other reagents or solvents were purchased from Sigma–Aldrich (MO, United States).
+ Open protocol
+ Expand
4

Functionalization of Amyloid-beta Peptide

Check if the same lab product or an alternative is used in the 5 most similar protocols
N-terminus azide modified Aβ42 [K(N3)-Aβ42] peptide was purchased from GenicBio Limited (Shanghai, China). MAL-PEG-SVA (M.wt 3400 g/mol) and mPEG-SVA (M.wt 2000 g/mol) were purchased from Laysan Bio (Arab, AL), Tris-(2-Carboxyethyl) phosphine-HCl (TCEP-HCl) was purchased from Hampton Research Inc. (CA, USA). NHS-PEG4-DBCO, and Cystamine, HCl were purchased from Sigma-Aldrich, USA. 1-(3-aminopropyl) silatrane (APS) were synthesized as described in ref23 . All other commercial solvents were purchased from Sigma-Aldrich (MO, USA). Water used in all the experiments is deionized (DI) water obtained from AquaMAX-ultra (APS water service corporation, USA) water purification system.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!